CRISPR Therapeutics AG
NASDAQ:CRSP
51.88 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.602 | 0.517 | 0.504 | 200 | 0 | 70 | 100 | 0.006 | 0.094 | 0.158 | 0.178 | 12.348 | 0.329 | 900.202 | 0.202 | 0.194 | 0.148 | 0.044 | 0.157 | 77.016 | 211.928 | 0.318 | 0.328 | 0.115 | 0.563 | 1.088 | 1.358 | 32.325 | 2.387 | 3.582 | 2.703 | 2.344 | 1.549 | 0.795 | 0.476 | 0.247 | 0 | 0 | 0 |
| Cost of Revenue
| 11.153 | 56.976 | 51.799 | 20 | 23.422 | 44.636 | 42.192 | 6.823 | 38.859 | 33.922 | 30.646 | 134.919 | 22.464 | 26.945 | 19.945 | 82.365 | 71.008 | 59.38 | 54.193 | 48.761 | 57.246 | 39.533 | 28.86 | 28.801 | 39.82 | 25.633 | 19.519 | 20.03 | 17.845 | 17.12 | 14.805 | 15.572 | 12.052 | 8.602 | 6.012 | 6.174 | 3.749 | 1.486 | 1.164 |
| Gross Profit
| -10.551 | -56.459 | -51.295 | 180 | -23.422 | 25.364 | 57.808 | -6.817 | -38.765 | -33.764 | -30.468 | -122.571 | -22.135 | 873.257 | -19.743 | -82.171 | -70.86 | -59.336 | -54.036 | 28.255 | 154.682 | -39.215 | -28.532 | -28.686 | -39.257 | -24.545 | -18.161 | 12.295 | -15.458 | -13.538 | -12.102 | -13.228 | -10.503 | -7.807 | -5.536 | -5.927 | -3.749 | -1.486 | -1.164 |
| Gross Profit Ratio
| -17.527 | -109.205 | -101.776 | 0.9 | 0 | 0.362 | 0.578 | -1,136.167 | -412.394 | -213.696 | -171.169 | -9.926 | -67.28 | 0.97 | -97.738 | -423.562 | -478.784 | -1,348.545 | -344.178 | 0.367 | 0.73 | -123.318 | -86.988 | -249.443 | -69.728 | -22.56 | -13.373 | 0.38 | -6.476 | -3.779 | -4.477 | -5.643 | -6.781 | -9.82 | -11.63 | -23.996 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 82.16 | 75.32 | 71.339 | 95.144 | 90.698 | 101.555 | 99.935 | 103.555 | 116.622 | 123.223 | 118.245 | 134.47 | 105.321 | 108.277 | 90.565 | 82.365 | 71.008 | 59.38 | 54.193 | 48.762 | 57.246 | 39.533 | 33.822 | 28.801 | 39.82 | 25.633 | 19.519 | 20.03 | 17.845 | 17.12 | 14.805 | 15.572 | 12.052 | 8.602 | 6.012 | 6.174 | 3.749 | 1.486 | 1.164 |
| General & Administrative Expenses
| 17.419 | 19.481 | 17.953 | 16.479 | 18.291 | 19.032 | 22.36 | 21.169 | 27.001 | 26.273 | 28.021 | 24.127 | 24.352 | 29.806 | 24.517 | 25.766 | 21.539 | 21.353 | 19.55 | 17.271 | 15.519 | 15.768 | 14.929 | 16.542 | 10.175 | 12.741 | 8.836 | 11.323 | 8.112 | 7.768 | 8.642 | 12.082 | 4.107 | 8.751 | 6.116 | 6.239 | 2.453 | 2.139 | 2.572 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 17.419 | 19.481 | 17.953 | 16.479 | 18.291 | 19.032 | 22.36 | 21.169 | 27.001 | 26.273 | 28.021 | 24.127 | 24.352 | 29.806 | 24.517 | 25.766 | 21.539 | 21.353 | 19.55 | 17.271 | 15.519 | 15.768 | 14.929 | 16.542 | 10.175 | 12.741 | 8.836 | 11.323 | 8.112 | 7.768 | 8.642 | 12.082 | 4.107 | 8.751 | 6.116 | 6.239 | 2.453 | 2.139 | 2.572 |
| Other Expenses
| 0 | 26.139 | 24.72 | 19.997 | 20.671 | 18.406 | 12.742 | 11.49 | 7.264 | 3.544 | -0.762 | 2.197 | 1.101 | 0.75 | 1.955 | 0.575 | 0.16 | 1.412 | 4.232 | 19.563 | 2.964 | 2.381 | 1.125 | -2.128 | -0.13 | 0.155 | -0.126 | 0.041 | -0.071 | -0.161 | -0.006 | 78.653 | -0.075 | 0.08 | -0.146 | 0.049 | 0.009 | 0 | 0 |
| Operating Expenses
| 99.579 | 94.801 | 89.292 | 110.417 | 108.989 | 120.587 | 122.295 | 124.724 | 143.623 | 149.496 | 145.504 | 158.046 | 129.178 | 137.584 | 114.745 | 107.955 | 92.547 | 80.733 | 73.743 | 66.033 | 72.765 | 55.301 | 48.751 | 45.343 | 49.995 | 38.374 | 28.355 | 31.353 | 25.957 | 24.888 | 23.447 | 27.654 | 16.159 | 17.353 | 12.128 | 12.413 | 6.202 | 2.11 | 2.643 |
| Operating Income
| -110.13 | -151.26 | -140.587 | 69.583 | -132.411 | -95.223 | -64.487 | -131.541 | -182.388 | -183.26 | -175.972 | -145.698 | -128.849 | 762.618 | -114.543 | -107.761 | -92.399 | -80.689 | -73.586 | 10.983 | 139.163 | -54.983 | -48.423 | -45.228 | -49.432 | -37.286 | -26.997 | 0.972 | -23.57 | -21.306 | -20.744 | -25.31 | -14.61 | -16.558 | -11.652 | -12.166 | -6.202 | -3.625 | -3.736 |
| Operating Income Ratio
| -182.94 | -292.573 | -278.942 | 0.348 | 0 | -1.36 | -0.645 | -21,923.5 | -1,940.298 | -1,159.873 | -988.607 | -11.799 | -391.638 | 0.847 | -567.045 | -555.469 | -624.318 | -1,833.841 | -468.701 | 0.143 | 0.657 | -172.903 | -147.631 | -393.287 | -87.801 | -34.27 | -19.88 | 0.03 | -9.874 | -5.948 | -7.674 | -10.798 | -9.432 | -20.828 | -24.479 | -49.255 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 25.064 | 26.139 | 24.72 | 19.997 | 20.671 | 18.406 | 12.742 | 11.49 | 7.264 | 3.544 | 0.363 | 2.197 | 1.101 | 0.75 | 1.955 | 0.575 | 0.16 | 1.412 | 4.232 | 19.563 | -0.466 | 1.369 | 0.1 | -2.128 | -1.142 | -0.998 | -1.217 | -0.412 | -0.43 | -0.666 | -0.452 | 42.807 | -0.075 | -0.606 | 11.336 | 0.049 | 0.009 | 0.028 | -0.071 |
| Income Before Tax
| -85.066 | -125.121 | -115.867 | 89.58 | -111.74 | -76.817 | -51.745 | -120.051 | -175.124 | -179.716 | -175.609 | -143.501 | -127.748 | 763.368 | -112.588 | -107.186 | -92.239 | -79.277 | -69.354 | 30.546 | 138.697 | -53.614 | -48.323 | -47.356 | -50.574 | -38.284 | -28.214 | 0.56 | -24 | -21.972 | -21.196 | 17.498 | -14.686 | -17.164 | -8.366 | -12.216 | -6.201 | -3.597 | -3.807 |
| Income Before Tax Ratio
| -141.306 | -242.014 | -229.895 | 0.448 | 0 | -1.097 | -0.517 | -20,008.5 | -1,863.021 | -1,137.443 | -986.567 | -11.621 | -388.292 | 0.848 | -557.366 | -552.505 | -623.236 | -1,801.75 | -441.745 | 0.397 | 0.654 | -168.597 | -147.326 | -411.791 | -89.829 | -35.188 | -20.776 | 0.017 | -10.054 | -6.134 | -7.842 | 7.465 | -9.481 | -21.59 | -17.576 | -49.457 | 0 | 0 | 0 |
| Income Tax Expense
| -0.876 | 1.287 | 0.724 | 0.233 | -0.412 | 0.923 | 1.32 | -9.476 | -0.575 | 6.118 | 3.608 | -2.253 | -0.595 | 4.143 | 0.575 | -0.147 | 0.2 | 0.379 | 0.377 | 0.004 | 0.274 | 0.085 | 0.085 | 0.234 | 0.137 | 0.096 | 0.086 | 0.419 | 0.707 | 0.343 | 0.279 | 0.4 | 0.008 | -0.606 | 0.076 | 0.07 | 0.153 | 0.069 | 0.285 |
| Net Income
| -85.942 | -126.408 | -116.591 | 89.347 | -112.152 | -77.74 | -53.065 | -110.575 | -174.549 | -185.834 | -179.217 | -141.248 | -127.153 | 759.225 | -113.163 | -107.039 | -92.439 | -79.656 | -69.731 | 30.542 | 138.423 | -53.699 | -48.408 | -47.59 | -50.711 | -38.38 | -28.3 | 0.141 | -24.707 | -22.315 | -21.475 | 17.098 | -14.694 | -17.164 | -8.442 | -12.286 | -6.354 | -3.643 | -3.237 |
| Net Income Ratio
| -142.761 | -244.503 | -231.331 | 0.447 | 0 | -1.111 | -0.531 | -18,429.167 | -1,856.904 | -1,176.165 | -1,006.837 | -11.439 | -386.483 | 0.843 | -560.213 | -551.747 | -624.588 | -1,810.364 | -444.146 | 0.397 | 0.653 | -168.865 | -147.585 | -413.826 | -90.073 | -35.276 | -20.839 | 0.004 | -10.351 | -6.23 | -7.945 | 7.294 | -9.486 | -21.59 | -17.735 | -49.741 | 0 | 0 | 0 |
| EPS
| -1.01 | -1.49 | -1.43 | 1.12 | -1.41 | -0.98 | -0.67 | -1.41 | -2.24 | -2.4 | -2.32 | -1.84 | -1.67 | 10.01 | -1.51 | -1.53 | -1.32 | -1.3 | -1.15 | 0.53 | 2.52 | -1.01 | -0.93 | -0.92 | -1.07 | -0.82 | -0.62 | 0.003 | -0.62 | -0.56 | -0.54 | 0.43 | -0.37 | -0.43 | -0.29 | -0.42 | -0.22 | -0.66 | -0.91 |
| EPS Diluted
| -1.01 | -1.49 | -1.43 | 1.1 | -1.41 | -0.98 | -0.67 | -1.41 | -2.24 | -2.4 | -2.32 | -1.84 | -1.67 | 9.44 | -1.51 | -1.53 | -1.32 | -1.3 | -1.15 | 0.51 | 2.4 | -1.01 | -0.93 | -0.92 | -1.07 | -0.82 | -0.62 | 0.003 | -0.62 | -0.56 | -0.54 | 0.43 | -0.37 | -0.43 | -0.29 | -0.42 | -0.22 | -0.66 | -0.91 |
| EBITDA
| -110.13 | -146.415 | -135.754 | 74.483 | -132.411 | -90.262 | -64.487 | -131.541 | -177.37 | -183.26 | -169.933 | -145.698 | -123.525 | 766.271 | -111.828 | -105.195 | -92.399 | -80.689 | -73.586 | 10.983 | 140.446 | -53.785 | -47.611 | -45.228 | -48.549 | -36.421 | -26.171 | 3.326 | -23.208 | -21.266 | -20.476 | 17.909 | -14.449 | -16.993 | -11.692 | -12.058 | -6.153 | -3.611 | -3.722 |
| EBITDA Ratio
| -182.94 | -283.201 | -269.353 | 0.372 | 0 | -1.289 | -0.645 | -21,923.5 | -1,886.915 | -1,159.873 | -954.68 | -11.799 | -375.456 | 0.851 | -553.604 | -542.242 | -624.318 | -1,833.841 | -468.701 | 0.143 | 0.663 | -169.135 | -145.155 | -393.287 | -86.233 | -33.475 | -19.272 | 0.103 | -9.723 | -5.937 | -7.575 | 7.64 | -9.328 | -21.375 | -24.563 | -48.818 | 0 | 0 | 0 |